Trial intelligence / Profile preview

CHOICE 2: Intra-arterial Alteplase after Mechanical Thrombectomy in Acute Ischemic Stroke

NCT05797792Phase 3Completed

Sponsor
Hospital Clínic de Barcelona
Start
Nov 2023
Primary completion
Aug 2025
Modality
rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 3 trial of tissue-plasminogen activator in ischemic stroke, sponsored by Hospital Clínic de Barcelona. Started Nov 2023; status: completed.

02

Drugs

tissue-plasminogen activator
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT05797792.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05797792.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call